Storys aus Switzerland

Luxochain SA

Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City

Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, has promoted an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. Lugano is increasingly a Blockchain & Crypto-Friendly City. After the launch at the ...

Luxochain SA

Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City

Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, has promoted an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. Lugano is increasingly a Blockchain & Crypto-Friendly City. After the launch at the ...

Luxochain SA

Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City.

Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, promotes an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. An unmissable opportunity to look into this new sector of digital art, discover ...

FDI World Dental Federation

FDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19 / Prescriptions of all other antibiotics fell during the same period

Debiopharm International SA

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos

Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...

Roche Diabetes Care

Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes

Basel, Switzerland (ots/PRNewswire) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with ...

The International Osteoporosis Foundation (IOF)

Action for bone health is needed now more than ever, urges IOF

Debiopharm International SA

CARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS

Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...

Debiopharm International SA

DEBIOPHARM & DEXA MEDICA LAUNCH TRIPTORELIN COLLABORATION TO BRING NEW HOPE TO WOMEN WITH ENDOMETRIOSIS

Lausanne, Switzerland – Tangerang, Indonesia (ots) - Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin for the treatment of women with gynecological disorders, ...

Synova S.A.

SYNOVA files lawsuit against Sitec for patent infringement

Debiopharm International SA

DEBIOPHARM ENCOURAGES BREAKTHROUGH CANCER RESEARCH IN JAPAN THROUGH ITS COMPETITIVE JCA MAUVERNAY AWARD

Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...

FDI World Dental Federation

2

How we can all help improve standards of care for children with clefts to optimize their oral health / FDI World Dental Federation (FDI) releases new educational resources to mark World Smile Day®

MAAG Music & Arts AG

2

World premiere: Viva Frida Kahlo – Immersive Experience

Justice Initiative

Child abuse in Europe: Victims' groups launch initiative to come to terms with European abuse cases

Bern, Switzerland (ots) - At an international meeting in Switzerland, victims' groups from all over Europe launched the large-scale "Justice Initiative". With this political initiative, abuse of children, especially in state and church institutions, is to be comprehensively dealt with for the first time in all European countries. A motion to bring the processing of ...

Kunstgesellschaft Grenchen - Triennale Grenchen

2

22nd Grenchen Triennial "Periphery of Overflow"

GSK Consumer Healthcare

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

Nyon, Switzerland (ots/PRNewswire) - New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. Today sees the launch of Let's treat it right, a major new health education campaign designed to bridge a knowledge gap ...

Synova S.A.

2

SYNOVA’s growth continues with new subsidiary in Germany

Anapaya Systems AG

Anapaya closes 6.8M CHF financing round with lead investor SIX Fintech Ventures

Debiopharm International SA

DEBIOPHARM AND UBIX THERAPEUTICS LAUNCH RESEARCH TO DEVELOP A NEW ANTI-CANCER MODALITY - ANTIBODY DEGRADUCER® CONJUGATES

Lausanne, Switzerland, Seoul, Republic of Korea (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech company today announced their co-research agreement combining two novel proprietary technologies to specifically ...

Wyss Academy for Nature

New forms of engagement at the Wyss Academy

Bern, Switzerland (ots) - The exhibition and meeting space "Habitat" of the Wyss Academy for Nature in Bern will newly present the work "Morphologies", which explores the moment of wonder towards nature that is common to art and science. At the same time, the Wyss Academy is addressing a pressing issue in the field of sustainable development: Engaging with people from research, politics, business, and agriculture on four ...

Debiopharm International SA

DEBIOPHARM’S CD37 ANTIBODY DRUG CONJUGATE SHOWS PROMISING PHASE II RESULTS FOR THE TREATMENT OF B-CELL MALIGNANCIES

Lausanne, Switzerland (ots) - - Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of Non-Hodgkin’s Lymphoma (NHL), representing 30-40% of cases. Nearly half of DLBCL patients are not cured by first-line treatment, leaving a large number of patients at risk of worsening disease1 - Naratuximab ...

Firmenich

Firmenich Pioneers A Revolutionary Natural Extraction Technology & Launches Firgood(TM) Ingredients

Geneva, Switzerland (ots/PRNewswire) - Firmenich, the world's largest privately-owned fragrance and taste company, unveils the Firgood(TM) collection, a brand new range of pure, 100% natural extracts obtained by a revolutionary, sustainable proprietary extraction technology. This patented process, pioneered by Firmenich, enables the processing of biomass never ...

4ARTechnologies

Art & Technology innovator 4ARTechnologies completes its unique ecosystem with secure NFT marketplace for physical and digital artworks

Synova S.A.

SYNOVA has filed an appeal against Avonisys with the Swiss Federal Supreme Court